Dare Bioscience, Inc. - COM (DARE)

Historical Portfolio Holders from Q3 2017 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
6.82 M
Holdings value Q1 2024
$3.35 M
Value change Q1 2024
+$123 K
Grand Portfolio weight change Q1 2024
+0%
Number of holders
34
Number of buys Q1 2024
14
Number of sells Q1 2024
-12
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
0%
CUSIP
23666P101
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 6.82 M $3.35 M +$123 K $0.49 34
2023 Q4 6.6 M $2.04 M -$2.97 M $0.31 33
2023 Q3 12.9 M $5.97 M +$2.89 M $0.46 30
2023 Q2 6.51 M $5.92 M -$381 K $0.91 27
2023 Q1 6.89 M $7.16 M -$95.1 K $1.04 29
2022 Q4 7.01 M $5.82 M -$364 K $0.83 30
2022 Q3 6.88 M $6.88 M +$26.3 K $1.00 26
2022 Q2 7.41 M $9.12 M +$930 K $1.23 34
2022 Q1 6.56 M $9.77 M -$798 K $1.49 33
2021 Q4 6.86 M $13.7 M +$5.86 M $2.00 36
2021 Q3 4.83 M $8.07 M +$2.37 M $1.67 32
2021 Q2 3.38 M $6.38 M -$377 K $1.89 29
2021 Q1 3.6 M $6.09 M -$2.2 M $1.69 25
2020 Q4 4.98 M $6.66 M +$3.7 M $1.34 22
2020 Q3 2.22 M $2.21 M +$591 K $1.00 16
2020 Q2 1.63 M $1.61 M +$651 K $0.99 15
2020 Q1 925 K $785 K +$88.6 K $0.85 15
2019 Q4 1.28 K $2 K -$27.7 K $1.57 2
2019 Q3 802 K $621 K -$39.8 K $0.77 12
2019 Q2 853 K $725 K -$4.97 K $0.85 11
2019 Q1 789 K $1.1 M +$129 K $1.40 13
2018 Q4 733 K $519 K -$498 $0.71 13
2018 Q3 10.9 K $11 K +$4 K $1.01 1
2018 Q2 768 K $898 K -$146 K $1.17 12
2018 Q1 1.03 M $863 K -$54.7 K $0.84 10
2017 Q4 482 K $1.04 M -$37 K $2.16 9
2017 Q3 486 K $1.52 M +$1.52 M $3.12 9